ELMSFORD, N.Y., April 24, 2014 /PRNewswire/
-- BioScrip®, Inc. (NASDAQ: BIOS) announced today
that the Company will release its 2014 first quarter financial
results on Thursday, May 8, 2014,
after the market closes.
The Company will host a conference call at 8:30 a.m. Eastern Daylight Time (EDT) on
Friday, May 9, 2014. Richard Smith, President and Chief Executive
Officer, and Hai Tran, Chief
Financial Officer, will conduct the call.
Interested parties may participate in the conference call by
dialing 800-896-0105 (US), or 212-231-2922 (International), 5-10
minutes prior to the start of the call. A replay of the conference
call will be available for two weeks after the call's completion by
dialing 800-633-8284 (US) or 402-977-9140 (International) and
entering conference call ID number 21715187. An audio webcast and
archive will also be available for 30 days under the "Investor
Relations" section of the BioScrip website at www.bioscrip.com.
About BioScrip, Inc.
BioScrip, Inc. is a leading national provider of infusion
solutions. BioScrip partners with physicians, healthcare payors,
government agencies, hospital systems and pharmaceutical
manufacturers to provide patients access to post-acute care
services. BioScrip operates with a commitment to deliver
customer-focused pharmacy and related healthcare infusion therapy
services in alternate-site settings. By collaborating with the full
spectrum of healthcare professionals and the patient, BioScrip
provides cost-effective care that is driven by quality, customer
service, and values that promote positive outcomes and an enhanced
quality of life for those it serves. BioScrip provides its infusion
services from 81 locations across 29 states.
SOURCE BioScrip, Inc.